Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes

Results from the botnia study

Muhammad A Abdul-ghani, Valeriya Lyssenko, Tiinamaija Tuomi, Ralph A Defronzo, Leif Groop

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

OBJECTIVE -The purpose of this study was to assess the efficacy of the postload plasma glucose concentration in predicting future risk of type 2 diabetes, compared with prediction models based on measurement of the fasting plasma glucose (FPG) concentration. RESEARCH DESIGN AND METHODS -A total of 2,442 subjects from the Botnia Study, who were free of type 2 diabetes at baseline, received an oral glucose tolerance test (OGTT) at baseline and after 7-8 years of follow-up. Future risk for type 2 diabetes was assessed with area under the receiver-operating characteristic curve for prediction models based up measurement of the FPG concentration 1) with or without a 1-h plasma glucose concentration during the OGTT and 2) with or without the metabolic syndrome. RESULTS -Prediction models based on measurement of the FPG concentration were weak predictors for the risk of future type 2 diabetes. Addition of a 1-h plasma glucose concentration markedly enhanced prediction of the risk of future type 2 diabetes. A cut point of 155 mg/dl for the 1-h plasma glucose concentration during the OGTT and presence of the metabolic syndrome were used to stratify subjects in each glucose tolerance group into low, intermediate, and high risk for future type 2 diabetes. CONCLUSIONS -The plasma glucose concentration at 1 h during the OGTT is a strong predictor of future risk for type 2 diabetes and adds to the prediction power of models based on measurements made during the fasting state. A plasma glucose cut point of 155 mg/dl plus the Adult Treatment Panel III criteria for the metabolic syndrome can be used to stratify nondiabetic subjects into low-, intermediate-, and high-risk groups.

Original languageEnglish (US)
Pages (from-to)281-286
Number of pages6
JournalDiabetes Care
Volume32
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Type 2 Diabetes Mellitus
Fasting
Glucose
Glucose Tolerance Test
ROC Curve
Research Design

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes : Results from the botnia study. / Abdul-ghani, Muhammad A; Lyssenko, Valeriya; Tuomi, Tiinamaija; Defronzo, Ralph A; Groop, Leif.

In: Diabetes Care, Vol. 32, No. 2, 02.2009, p. 281-286.

Research output: Contribution to journalArticle

Abdul-ghani, Muhammad A ; Lyssenko, Valeriya ; Tuomi, Tiinamaija ; Defronzo, Ralph A ; Groop, Leif. / Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes : Results from the botnia study. In: Diabetes Care. 2009 ; Vol. 32, No. 2. pp. 281-286.
@article{5d825e3bb1a74e19903625a5200c99ee,
title = "Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: Results from the botnia study",
abstract = "OBJECTIVE -The purpose of this study was to assess the efficacy of the postload plasma glucose concentration in predicting future risk of type 2 diabetes, compared with prediction models based on measurement of the fasting plasma glucose (FPG) concentration. RESEARCH DESIGN AND METHODS -A total of 2,442 subjects from the Botnia Study, who were free of type 2 diabetes at baseline, received an oral glucose tolerance test (OGTT) at baseline and after 7-8 years of follow-up. Future risk for type 2 diabetes was assessed with area under the receiver-operating characteristic curve for prediction models based up measurement of the FPG concentration 1) with or without a 1-h plasma glucose concentration during the OGTT and 2) with or without the metabolic syndrome. RESULTS -Prediction models based on measurement of the FPG concentration were weak predictors for the risk of future type 2 diabetes. Addition of a 1-h plasma glucose concentration markedly enhanced prediction of the risk of future type 2 diabetes. A cut point of 155 mg/dl for the 1-h plasma glucose concentration during the OGTT and presence of the metabolic syndrome were used to stratify subjects in each glucose tolerance group into low, intermediate, and high risk for future type 2 diabetes. CONCLUSIONS -The plasma glucose concentration at 1 h during the OGTT is a strong predictor of future risk for type 2 diabetes and adds to the prediction power of models based on measurements made during the fasting state. A plasma glucose cut point of 155 mg/dl plus the Adult Treatment Panel III criteria for the metabolic syndrome can be used to stratify nondiabetic subjects into low-, intermediate-, and high-risk groups.",
author = "Abdul-ghani, {Muhammad A} and Valeriya Lyssenko and Tiinamaija Tuomi and Defronzo, {Ralph A} and Leif Groop",
year = "2009",
month = "2",
doi = "10.2337/dc08-1264",
language = "English (US)",
volume = "32",
pages = "281--286",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes

T2 - Results from the botnia study

AU - Abdul-ghani, Muhammad A

AU - Lyssenko, Valeriya

AU - Tuomi, Tiinamaija

AU - Defronzo, Ralph A

AU - Groop, Leif

PY - 2009/2

Y1 - 2009/2

N2 - OBJECTIVE -The purpose of this study was to assess the efficacy of the postload plasma glucose concentration in predicting future risk of type 2 diabetes, compared with prediction models based on measurement of the fasting plasma glucose (FPG) concentration. RESEARCH DESIGN AND METHODS -A total of 2,442 subjects from the Botnia Study, who were free of type 2 diabetes at baseline, received an oral glucose tolerance test (OGTT) at baseline and after 7-8 years of follow-up. Future risk for type 2 diabetes was assessed with area under the receiver-operating characteristic curve for prediction models based up measurement of the FPG concentration 1) with or without a 1-h plasma glucose concentration during the OGTT and 2) with or without the metabolic syndrome. RESULTS -Prediction models based on measurement of the FPG concentration were weak predictors for the risk of future type 2 diabetes. Addition of a 1-h plasma glucose concentration markedly enhanced prediction of the risk of future type 2 diabetes. A cut point of 155 mg/dl for the 1-h plasma glucose concentration during the OGTT and presence of the metabolic syndrome were used to stratify subjects in each glucose tolerance group into low, intermediate, and high risk for future type 2 diabetes. CONCLUSIONS -The plasma glucose concentration at 1 h during the OGTT is a strong predictor of future risk for type 2 diabetes and adds to the prediction power of models based on measurements made during the fasting state. A plasma glucose cut point of 155 mg/dl plus the Adult Treatment Panel III criteria for the metabolic syndrome can be used to stratify nondiabetic subjects into low-, intermediate-, and high-risk groups.

AB - OBJECTIVE -The purpose of this study was to assess the efficacy of the postload plasma glucose concentration in predicting future risk of type 2 diabetes, compared with prediction models based on measurement of the fasting plasma glucose (FPG) concentration. RESEARCH DESIGN AND METHODS -A total of 2,442 subjects from the Botnia Study, who were free of type 2 diabetes at baseline, received an oral glucose tolerance test (OGTT) at baseline and after 7-8 years of follow-up. Future risk for type 2 diabetes was assessed with area under the receiver-operating characteristic curve for prediction models based up measurement of the FPG concentration 1) with or without a 1-h plasma glucose concentration during the OGTT and 2) with or without the metabolic syndrome. RESULTS -Prediction models based on measurement of the FPG concentration were weak predictors for the risk of future type 2 diabetes. Addition of a 1-h plasma glucose concentration markedly enhanced prediction of the risk of future type 2 diabetes. A cut point of 155 mg/dl for the 1-h plasma glucose concentration during the OGTT and presence of the metabolic syndrome were used to stratify subjects in each glucose tolerance group into low, intermediate, and high risk for future type 2 diabetes. CONCLUSIONS -The plasma glucose concentration at 1 h during the OGTT is a strong predictor of future risk for type 2 diabetes and adds to the prediction power of models based on measurements made during the fasting state. A plasma glucose cut point of 155 mg/dl plus the Adult Treatment Panel III criteria for the metabolic syndrome can be used to stratify nondiabetic subjects into low-, intermediate-, and high-risk groups.

UR - http://www.scopus.com/inward/record.url?scp=61849140099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849140099&partnerID=8YFLogxK

U2 - 10.2337/dc08-1264

DO - 10.2337/dc08-1264

M3 - Article

VL - 32

SP - 281

EP - 286

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 2

ER -